Literature DB >> 22780198

O-Nucleoside, S-nucleoside, and N-nucleoside probes of lumazine synthase and riboflavin synthase.

Arindam Talukdar1, Yujie Zhao, Wei Lv, Adelbert Bacher, Boris Illarionov, Markus Fischer, Mark Cushman.   

Abstract

Lumazine synthase catalyzes the penultimate step in the biosynthen class="Chemical">sis of riboflavin, while riboflavin synthase catalyzes the last step. O-Nucleoside, S-nucleoside, and N-nucleoside analogues of hypothetical lumazine biosynthetic intermediates have been synthesized in order to obtain structure and mechanism probes of these two enzymes, as well as inhibitors of potential value as antibiotics. Methods were devised for the selective cleavage of benzyl protecting groups in the presence of other easily reduced functionality by controlled hydrogenolysis over Lindlar catalyst. The deprotection reaction was performed in the presence of other reactive functionality including nitro groups, alkenes, and halogens. The target compounds were tested as inhibitors of lumazine synthase and riboflavin synthase obtained from a variety of microorganisms. In general, the S-nucleosides and N-nucleosides were more potent than the corresponding O-nucleosides as lumazine synthase and riboflavin synthase inhibitors, while the C-nucleosides were the least potent. A series of molecular dynamics simulations followed by free energy calculations using the Poisson-Boltzmann/surface area (MM-PBSA) method were carried out in order to rationalize the results of ligand binding to lumazine synthase, and the results provide insight into the dynamics of ligand binding as well as the molecular forces stabilizing the intermediates in the enzyme-catalyzed reaction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22780198      PMCID: PMC3444172          DOI: 10.1021/jo3010364

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  48 in total

1.  Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthase.

Authors:  Arindam Talukdar; Ekaterina Morgunova; Jianxin Duan; Winfried Meining; Nicolas Foloppe; Lennart Nilsson; Adelbert Bacher; Boris Illarionov; Markus Fischer; Rudolf Ladenstein; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2010-04-08       Impact factor: 3.641

2.  Mechanistic insights on riboflavin synthase inspired by selective binding of the 6,7-dimethyl-8-ribityllumazine exomethylene anion.

Authors:  Ryu-Ryun Kim; Boris Illarionov; Monika Joshi; Mark Cushman; Chan Yong Lee; Wolfgang Eisenreich; Markus Fischer; Adelbert Bacher
Journal:  J Am Chem Soc       Date:  2010-03-10       Impact factor: 15.419

3.  Structural and thermodynamic insights into the binding mode of five novel inhibitors of lumazine synthase from Mycobacterium tuberculosis.

Authors:  Ekaterina Morgunova; Boris Illarionov; Thota Sambaiah; Ilka Haase; Adelbert Bacher; Mark Cushman; Markus Fischer; Rudolf Ladenstein
Journal:  FEBS J       Date:  2006-09-19       Impact factor: 5.542

4.  The atomic structure of pentameric lumazine synthase from Saccharomyces cerevisiae at 1.85 A resolution reveals the binding mode of a phosphonate intermediate analogue.

Authors:  W Meining; S Mörtl; M Fischer; M Cushman; A Bacher; R Ladenstein
Journal:  J Mol Biol       Date:  2000-05-26       Impact factor: 5.469

5.  Robust Salmonella metabolism limits possibilities for new antimicrobials.

Authors:  Daniel Becker; Matthias Selbach; Claudia Rollenhagen; Matthias Ballmaier; Thomas F Meyer; Matthias Mann; Dirk Bumann
Journal:  Nature       Date:  2006-03-16       Impact factor: 49.962

6.  A new series of N-[2,4-dioxo-6-d-ribitylamino-1,2,3,4-tetrahydropyrimidin-5-yl]oxalamic acid derivatives as inhibitors of lumazine synthase and riboflavin synthase: design, synthesis, biochemical evaluation, crystallography, and mechanistic implications.

Authors:  Yanlei Zhang; Boris Illarionov; Ekaterina Morgunova; Guangyi Jin; Adelbert Bacher; Markus Fischer; Rudolf Ladenstein; Mark Cushman
Journal:  J Org Chem       Date:  2008-03-11       Impact factor: 4.354

7.  A new series of 3-alkyl phosphate derivatives of 4,5,6,7-tetrahydro-1-D-ribityl-1H-pyrazolo[3,4-d]pyrimidinedione as inhibitors of lumazine synthase: design, synthesis, and evaluation.

Authors:  Yanlei Zhang; Guangyi Jin; Boris Illarionov; Adelbert Bacher; Markus Fischer; Mark Cushman
Journal:  J Org Chem       Date:  2007-08-18       Impact factor: 4.354

8.  (15)N{(31)P} REDOR NMR studies of the binding of phosphonate reaction intermediate analogues to Saccharomyces cerevisiae lumazine synthase.

Authors:  Tsyr-Yan Yu; Robert D O'Connor; Astrid C Sivertsen; Colby Chiauzzi; Barbara Poliks; Markus Fischer; Adelbert Bacher; Ilka Haase; Mark Cushman; Jacob Schaefer
Journal:  Biochemistry       Date:  2008-12-30       Impact factor: 3.162

9.  Synthesis and enzyme inhibitory activity of the s-nucleoside analogue of the ribitylaminopyrimidine substrate of lumazine synthase and product of riboflavin synthase.

Authors:  Arindam Talukdar; Boris Illarionov; Adelbert Bacher; Markus Fischer; Mark Cushman
Journal:  J Org Chem       Date:  2007-08-16       Impact factor: 4.354

10.  Discovery and development of a small molecule library with lumazine synthase inhibitory activity.

Authors:  Arindam Talukdar; Meghan Breen; Adelbert Bacher; Boris Illarionov; Markus Fischer; Gunda Georg; Qi-Zhuang Ye; Mark Cushman
Journal:  J Org Chem       Date:  2009-08-07       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.